Adam Sutton is a Dermatology physician affiliated with University of Nebraska at Omaha. OpenAlex indexes 68 publications with 315 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4014 Leavenworth St
Omaha, NE 681051053
Telephone
402-552-7928Registry record last updated 6 Dec 2018.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- ABBVIE INC.Program year20241 payment
- Horizon Therapeutics plcProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
36.9%Gabapentinoids24.9%Pregabalin100%Part D≥50 patientsBenzodiazepine12%Alprazolam58%Diazepam42%Part D≥15 patientsAnti-infectives
30.4%First-generation cephalosporins13.8%Cefadroxil100%Part D≥25 patientsTetracycline-class Drug8.8%Doxycycline Hyclate100%Part D≥16 patients+ 1 more class in this area
Cancer & immunology
18.9%Nucleoside Metabolic Inhibitor18.9%Fluorouracil100%Part D≥31 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort study
Journal of the American Academy of Dermatology
2025 - Mortality and Major Amputation in Patients With Diabetes‐Related Foot Ulcers and Chronic Renal Disease
ANZ Journal of Surgery
2025 - Hidradenocarcinoma: A Rare but Challenging Sweat Gland Neoplasm
Graduate Medical Education Research Journal
2025 - Evaluating Adherence to Recommended General Dermatology Follow-Up After Mohs Surgery
Dermatologic Surgery
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Rennard, MD
University of Nebraska at Omaha
Philip Bierman, MD
University of Nebraska at Omaha
Rudy Lackner, MD
University of Nebraska at Omaha
Iraklis Pipinos, MD
University of Nebraska at Omaha
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”